Apelin Gene Therapy Increases Autophagy Via Activation of Sirtuin 3 in Diabetic Heart
DOI:
https://doi.org/10.17140/DROJ-1-115Keywords:
Sirtuin 3 Autophagy ROS, Apoptosis, Myocardial infarction, DiabetesAbstract
Heart failure is the leading cause of death in diabetic patients. Recently we showed that apelin gene therapy attenuates heart failure following myocardial infarction. This study further explored the potential mechanisms by which apelin may reduce cardiac injury in Postmyocardial infarction (MI)) model of diabetes. Wild type and Sirt3 knockout (Sirt3 KO) mice were induced into diabetes by intra-peritoneal (i.p.) Streptozotocin (STZ). STZ mice were then subjected to MI followed by immediate intramyocardial injection with Adenovirus-apelin (Adapelin). Ad-apelin treatment resulted in over expression of apelin in the ischemic hearts of STZ mice. Apelin over expression led to a significant increase in Sirt3 expression. Apelin over expression significantly reduced gp91phox expression. This was accompanied by a significant reduction of reactive oxygen species formation. Ad-apelin treatment also dramatically reduced
NF-κb-p65 expression in WT-STZ mice. Over expression of apelin further enhanced autophagy markers (LC3-II and beclin-1) expression in post-MI heart. Most intriguingly, knockout of Sirt3 in STZ mice abolished these beneficial effects of apelin treatment. In vitro, knockout of Sirt3 in EPCs significantly enhanced high glucose-induced ROS formation. Conversely, treatment of Sirt3 KO-EPCs with NADPH oxidase inhibitor led to two fold increase in LC3-II levels. Our studies demonstrate that apelin increases autophagy via up regulation of Sirt3 and suppression of ROS-NF-κb pathway in diabetic heart.
References
Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol. 2001; 38: 421-428. doi: 10.1016/S0735-1097(01)01408-5
Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA. 2002; 28(7): 2570-2581. doi: 10.1001/ jama.287.19.2570
Buyken AE, von Eckardstein A, Schulte H, Cullen P, Assmann G. Type 2 diabetes mellitus and risk of coronary heart disease: Results of the 10-year follow-up of the procam study. Eur J Cardiovasc Prev Rehabil. 2007; 14: 230-236. doi: 10.1097/ HJR.0b013e3280142037
Song SH, Brown PM. Coronary heart disease risk assessment in diabetes mellitus: Comparison of ukpds risk engine with framingham risk assessment function and its clinical implications. Diabet Med. 2004; 21: 238-245. doi: 10.1111/j.1464-5491.2004.01116.x
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339: 229-234. doi: 10.1056/NEJM199807233390404
Cox CM, D’Agostino SL, Miller MK, Heimark RL, Krieg PA. Apelin, the ligand for the endothelial g-protein-coupled receptor, apj, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol. 2006; 296: 177-189. doi: 10.1016/j.ydbio.2006.04.452
Li L, Zeng H, Chen JX. Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction. Am J Physiol Heart Circ Physiol. 2012; 303: H605-H618. doi: 10.1152/ajpheart.00366.2012
Wang W, McKinnie SM, Patel VB, et al. Loss of apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: Therapeutic potential of synthetic apelin analogues. J Am Heart Assoc. 2013; 2: e000249. doi: 10.1161/JAHA.113.000249
Hou X, Zeng H, He X, Chen JX. Sirt3 is essential for apelin-induced angiogenesis in post-myocardial infarction of diabetes. J Cell Mol Med. 2015; 19: 53-61. doi: 10.1111/jcmm.12453
Shi T, Wang F, Stieren E, Tong Q. Sirt3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem. 2005; 280: 13560-13567.
Giralt A, Villarroya F. Sirt3, a pivotal actor in mitochondrial functions: Metabolism, cell death and aging. Biochem J. 2012; 444: 1-10. doi: 10.1042/BJ20120030
Li L, Zeng H, Hou X, He X, Chen JX. Myocardial injection of apelin-overexpressing bone marrow cells improves cardiac repair via upregulation of sirt3 after myocardial infarction. PLoS One. 2013; 8: e71041. doi: 10.1371/journal.pone.0071041
Zhao T, Li J, Chen AF. Microrna-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab. 2010; 299: E110-E116. doi: 10.1152/ ajpendo.00192.2010
Zeng H, He X, Hou X, Li L, Chen JX. Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3. Am J Physiol Heart Circ Physiol. 2014; 306: H585-H597. doi: 10.1152/ ajpheart.00821.2013
Mizumura K, Choi AM, Ryter SW. Emerging role of selective autophagy in human diseases. Front Pharmacol. 2014; 5: 244. doi: 10.3389/fphar.2014.00244
Iglewski M, Hill JA, Lavandero S, Rothermel BA. Mitochondrial fission and autophagy in the normal and diseased heart. Curr Hypertens Rep. 2010; 12: 418-425. doi: 10.1007/ s11906-010-0147-x
Omatsu-Kanbe M, Matsuura H. Ischemic survival and constitutively active autophagy in self-beating atypically-shaped cardiomyocytes (acms): Characterization of a new subpopulation of heart cells. J Physiol Sci. 2013; 63: 17-29. doi: 10.1007/s12576-012-0236-5
Maeda H, Nagai H, Takemura G, et al. Intermittent-hypoxia induced autophagy attenuates contractile dysfunction and myocardial injury in rat heart. Biochim Biophys Acta. 2013; 1832: 1159-1166. doi: 10.1016/j.bbadis.2013.02.014
Hamacher-Brady A, Brady NR, Gottlieb RA, Gustafsson AB. Autophagy as a protective response to bnip3-mediated apoptotic signaling in the heart. Autophagy. 2006; 2: 307-309.
Hamacher-Brady A, Brady NR, Gottlieb RA. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem. 2006; 281: 29776-29787.
Wu X, He L, Chen F, et al. Impaired autophagy contributes to adverse cardiac remodeling in acute myocardial infarction. PLoS One. 2014; 9: e112891. doi: 10.1371/journal.pone.0112891
Cahill-Smith S, Li JM. Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: A role of nadph oxidase 2. Br J Clin Pharmacol. 2014; 78: 441-453. doi: 10.1111/bcp.12357
Krijnen PA, Meischl C, Hack CE, et al. Increased nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol. 2003; 56: 194-199.
Somasuntharam I, Boopathy AV, Khan RS, et al. Delivery of nox2-nadph oxidase sirna with polyketal nanoparticles for improving cardiac function following myocardial infarction. Biomaterials. 2013; 34: 7790-7798. doi: 10.1016/j. biomaterials.2013.06.051
Parajuli N, Patel VB, Wang W, Basu R, Oudit GY. Loss of nox2 (gp91phox) prevents oxidative stress and progression to advanced heart failure. Clin Sci (Lond). 2014; 127: 331-340. doi: 10.1042/CS20130787
Ahn BH, Kim HS, Song S, et al. A role for the mitochondrial deacetylase sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA. 2008; 105: 14447-14452. doi: 10.1073/ pnas.0803790105
Jing E, O’Neill BT, Rardin MJ, et al. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes. 2013; 62: 3404-3417. doi: 10.2337/db12-1650
Hirschey MD, Shimazu T, Goetzman E, et al. Sirt3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 2010; 464: 121-125. doi: 10.1038/ nature08778
Dai SH, Chen T, Wang YH, et al. Sirt3 attenuates hydrogen peroxide-induced oxidative stress through the preservation of mitochondrial function in ht22 cells. Int J Mol Med. 2014; 34: 1159-1168. doi: 10.3892/ijmm.2014.1876
Sciarretta S, Yee D, Ammann P, et al. Role of nadph oxidase in the regulation of autophagy in cardiomyocytes. Clin Sci (Lond). 2015; 128: 387-403. doi: 10.1042/CS20140336
Zeng H, Li L, Chen JX. Loss of sirt3 limits bone marrow cell-mediated angiogenesis and cardiac repair in post-myocardial infarction. PLoS One. 2014; 9: e107011. doi: 10.1371/journal. pone.0107011
Chang CP, Su YC, Lee PH, Lei HY. Targeting nfkb by autophagy to polarize hepatoma-associated macrophage differentiation. Autophagy. 2013; 9: 619-621. doi: 10.4161/ auto.23546
Chiavarina B, Whitaker-Menezes D, Migneco G, et al. Hif1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis. Cell Cycle. 2010; 9: 3534-3551. doi: 10.4161/cc.9.17.12908
Martinez-Outschoorn UE, Trimmer C, Lin Z, et al.Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, hif1 induction and nfkappab activation in the tumor stromal microenvironment. Cell Cycle. 2010; 9: 3515- 3533.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Diabetes Research (DR) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.